Incannex Healthcare (IXHL) Change in Cash (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Change in Cash of $2.2 million for Q1 2026, down 51.21% year-on-year from $4.6 million in Q1 2025, and up 160.46% on a QoQ basis from -$3.7 million in Q4 2025.
Incannex Healthcare (IXHL) Change in Cash (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Change in Cash for 4 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Cash fell 51.21% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.6 million (up 2313.32% YoY) and the FY2025 annual result came in at $8.9 million, up 155.05% from the prior year.
- Change in Cash improved to $2.2 million in Q1 2026 per IXHL's latest filing, from -$3.7 million in the prior quarter.
- Over the last five years, Change in Cash for IXHL reached as high as $58.0 million in Q3 2025 and fell as low as -$5.8 million in Q3 2023.
- A 4-year average of $3.4 million and a median of -$2.3 million in 2023 frame the typical range for Change in Cash.
- The largest YoY upside for Change in Cash was 2682.27% in 2025 against a maximum downside of 133.44% in 2025.
- Year by year, Change in Cash stood at -$2.3 million in 2023, then soared by 30.79% to -$1.6 million in 2024, then sank by 133.44% to -$3.7 million in 2025, then soared by 160.46% to $2.2 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $2.2 million, -$3.7 million, and $58.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | -3.70 Mn |
| Sep 30, 2025 | 57.97 Mn |
| Jun 30, 2025 | 8.12 Mn |
| Mar 31, 2025 | 4.59 Mn |
| Dec 31, 2024 | -1.59 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Jun 30, 2024 | -3.68 Mn |
| Mar 31, 2024 | -4.32 Mn |
| Dec 31, 2023 | -2.29 Mn |
| Sep 30, 2023 | -5.84 Mn |
| Jun 30, 2023 | -2.79 Mn |
| Mar 31, 2023 | -2.84 Mn |